Acquire Develop Out-License

Delivery and Execution

Our development approach allows us to get drugs to patients sooner

Drug Development Roadmap

Our experienced team understands the interdependencies that create efficiencies in clinical development and uses this knowledge to drive improved outcomes

Novel trial design using Bayesian thinking and sequential learning, drives improved results

Trial Design

OMIC Analysis

Appropriate scientific analyses to evidence tumour type selection


Ensuring the right patients are always recruited to the right trials

Clinical Trial


Appropriate additional tumour types investigated, creating incremental asset value

Legal & IP

Legal patent maintenance and new IP filing capturing future value for out-license partners


Clinical and pre-clinical processes: chemistry, manufacturing and control done early in process


Deep analytics driven approach to understand market, pricing and competitive landscape


Reliability and robustness of electronic submissions and filings


Managing interactions and ensuring efficient approvals


Royalty agreements with larger pharmaceutical companies for marketing and distribution

A Patient focused trial design process based on our deep understanding of how the drug can commercially make it to market

Optimising the way we deliver projects through our functional service provider model

Our dedicated and experienced in-house team facilitates the interface with functional providers to scale our operations, drive efficiency, problem solving and patient advocacy whilst overseeing the entirety of the development process, through to out-license

Speak to us about being a service provider

Contact us